Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies

Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies

Induced pluripotent stem (iPS) cells are laboratory-produced cells that combine the biological advantages of somatic adult and stem cells for cell-based therapy. The reprogramming of cells, such as fibroblasts, to an embryonic stem cell-like state is done by the ectopic expression of transcription f...

Full description

Bibliographic Details
Main Authors:	Daniela Gois Beghini, Samuel Iwao Horita, Cynthia Machado Cascabulho, Luiz Anastácio Alves, Andrea Henriques-Pons
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	International Journal of Molecular Sciences
Subjects:	induced pluripotent stem cells regeneration cellular therapy stem cells muscular dystrophy
Online Access:	https://www.mdpi.com/1422-0067/21/15/5467

Similar Items

Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients
by: Wenqiang Liu, et al.
Published: (2023-10-01)

Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
by: Lubos Danisovic, et al.
Published: (2018-12-01)

Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies
by: Celine Bruge, et al.
Published: (2022-06-01)

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
by: Ruojie He, et al.
Published: (2020-05-01)

Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I
by: Karim Azzag, et al.
Published: (2020-04-01)

Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy
by: Chunhui Jiang, et al.
Published: (2014-08-01)

Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
by: Kantaro Yoshioka, et al.
Published: (2021-09-01)

Duchenne muscular dystrophy: overview and future challenges
by: Moh Hasan Machfoed, et al.
Published: (2017-11-01)

Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis
by: Ariadna Bargiela, et al.
Published: (2022-08-01)

Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset
by: Virginie Mournetas, et al.
Published: (2021-02-01)

Implications of notch signaling in duchenne muscular dystrophy
by: Lily Den Hartog, et al.
Published: (2022-09-01)

Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
by: Elena Abati, et al.
Published: (2021-09-01)

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling
by: Daniela Gois Beghini, et al.
Published: (2024-02-01)

DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patient
by: Simona Ruggieri, et al.
Published: (2019-01-01)

Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery
by: Ricardo Mondragon-Gonzalez, et al.
Published: (2018-07-01)

Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
by: Vittoria Marini, et al.
Published: (2022-08-01)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
by: Binyamin Eisen, et al.
Published: (2023-05-01)

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy
by: Agnieszka Łoboda, et al.
Published: (2024-01-01)

Acquisition and maintenance of pluripotency are influenced by fibroblast growth factor, leukemia inhibitory factor, and 2i in bovine-induced pluripotent stem cells
by: Ramon Cesar Botigelli, et al.
Published: (2022-09-01)

Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
by: Kasun Kodippili, et al.
Published: (2023-05-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

In vivo PSC differentiation as a platform to identify factors for improving the engraftability of cultured muscle stem cells
by: Ning Xie, et al.
Published: (2024-02-01)

Efficient Muscle Regeneration by Human PSC-Derived CD82<sup>+</sup> ERBB3<sup>+</sup> NGFR<sup>+</sup> Skeletal Myogenic Progenitors
by: Ning Xie, et al.
Published: (2023-01-01)

Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology
by: N. Rawat, et al.
Published: (2017-06-01)

Collagen-VI supplementation by cell transplantation improves muscle regeneration in Ullrich congenital muscular dystrophy model mice
by: Nana Takenaka-Ninagawa, et al.
Published: (2021-08-01)

Metabolomic Analyses Reveal Extensive Progenitor Cell Deficiencies in a Mouse Model of Duchenne Muscular Dystrophy
by: Josiane Joseph, et al.
Published: (2018-10-01)

Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy
by: Yuko Nitahara-Kasahara, et al.
Published: (2021-01-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

“The Social Network” and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies
by: Ornella Cappellari, et al.
Published: (2020-07-01)

Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1
by: Noémie Bérenger-Currias, et al.
Published: (2023-02-01)

Generation of sibling-matched induced pluripotent stem cell lines from spinal and bulbar muscular atrophy patients
by: Gunaseelan Narayanan, et al.
Published: (2017-04-01)

Pluripotency and its layers of complexity
by: Jolene Ooi, et al.
Published: (2012-01-01)

The use of umbilical cord‐derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real‐life settings
by: Beata Świątkowska‐Flis, et al.
Published: (2021-10-01)

Keeping your strength up: induced pluripotent stem cell-based approaches for the treatment and investigation of skeletal muscle disorders
by: Hyun-Jun Kim, et al.
Published: (2023-12-01)

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy
by: Aleksandra Klimczak, et al.
Published: (2020-04-01)

Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
by: Junio Dort, et al.
Published: (2023-08-01)

“Betwixt Mine Eye and Heart a League Is Took”: The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy
by: Davide Rovina, et al.
Published: (2020-09-01)